Wei‐Heng Xu
- Molecular Biology
- Pharmacology top 10%
- Epidemiology
- Pharmacology top 5%
- Hepatology top 10%
- Topics
- Bioactive natural compounds (5 papers)Liver physiology and pathology (4 papers)Liver Disease Diagnosis and Treatment (4 papers)
- Cited by
- HepatologyPharmacologyBiotechnology
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Wei‐Heng Xu
29 papers receiving 618 citations
Peers
Comparison fields: 5 of 94
- Molecular Biology 302
- Pharmacology 105
- Epidemiology 101
- Pharmacology 83
- Hepatology 83
Countries citing papers authored by Wei‐Heng Xu
This map shows the geographic impact of Wei‐Heng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Heng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Heng Xu more than expected).
Fields of papers citing papers by Wei‐Heng Xu
This network shows the impact of papers produced by Wei‐Heng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Heng Xu. The network helps show where Wei‐Heng Xu may publish in the future.
Co-authorship network of co-authors of Wei‐Heng Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Heng Xu. A scholar is included among the top collaborators of Wei‐Heng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Heng Xu. Wei‐Heng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 10 | |
| 7 | 0 | |
| 8 | 5 | |
| 9 | 13 | |
| 10 | 13 | |
| 11 | 22 | |
| 12 | 36 | |
| 13 | 2 | |
| 14 | 46 | |
| 15 | 38 | |
| 16 | 18 | |
| 17 | 19 | |
| 18 | 21 | |
| 19 | 48 | |
| 20 | 106 |
About Wei‐Heng Xu
Wei‐Heng Xu is a scholar working on Hepatology, Biotechnology and Pharmacology, having authored 31 papers that have together received 630 indexed citations. Recurring topics across this work include Bioactive natural compounds (5 papers), Liver physiology and pathology (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). The work is most often cited by research in Hepatology (83 citations), Pharmacology (83 citations) and Biotechnology (61 citations). Wei‐Heng Xu has collaborated with scholars based in China, United States and India. Frequent co-authors include Junping Zhang, Cheng Guo, Zhenlin Hu, Lei Qiu, Xing Deng, Honggang Hu, Jie Li, ZhongXiang Zhang, Xingxia Li and Jing Wang. Their work appears in journals such as Hepatology, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.